| Issue |
Section |
Title |
File |
| Vol 24, No 1 (2024) |
Oncology |
Preface |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Tumor-associated Macrophages Mediate Gefitinib Resistance in Lung Cancer through HGF/c-met Signaling Pathway |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Cell Death Induced by the Combination of Ephedra sinica Extract and Radiation in HNSCC is Positively Related to BAX and p-MLKL Expression |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Cellular and DNA Toxicity Study of Triphenyltin Ethyl Phenyl Dithiocarbamate and Triphenyltin Butyl Phenyl Dithiocarbamate on K562, Leukemia Cell Line |
(Eng)
|
| Vol 24, No 1 (2024) |
Oncology |
Green Synthesis of a Novel Phytoalexin Derivative: In Silico Profiling, Apoptotic Induction, and Antiproliferative Activity against MCF-7 cells - From Vineyards to Potent Anticancer Drug Molecule |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Hyperoxic-hypoxic Paradox: Breast Cancer Microenvironment and an Innovative Treatment Strategy |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Recent Advances in Chemistry, Mechanism, and Applications of Quantum Dots in Photodynamic and Photothermal Therapy |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Anticancer Activity of Sargassum fluitans Extracts in Different Cancer Cells |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma In vitro and In vivo |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Phytol and α-Bisabolol Synergy Induces Autophagy and Apoptosis in A549 Cells and Additional Molecular Insights through Comprehensive Proteome Analysis via Nano LC-MS/MS |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Investigating the Effects of Dorema hyrcanum Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines |
(Eng)
|
| Vol 24, No 10 (2024) |
Oncology |
Bee Venom Toxic Effect on MDA-MB-231 Breast Cancer Cells and Caenorhabditis Elegans |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated BTKCys481 Waldenström Macroglobulinemia: A Computational Approach |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Anti-tumoral Immunity and Chemo-preventive Effectiveness of Herbal Extracts of Curcumin, Ginger, Clove and Amygdaline in Ehrlich Ascites Carcinoma-Challenging Mice |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Arnicolide D Inhibits Oxidative Stress-induced Breast Cancer Cell Growth and Invasion through Apoptosis, Ferroptosis, and Parthanatos |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Anti-Cancer Activity of Synthesized 5-Benzyl juglone on Selected Human Cancer Cell Lines |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Gastrodin Attenuates Colitis and Prevents Tumorigenesis in Mice by Interrupting TLR4/MD2/NF-κB Signaling Transduction |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) |
(Eng)
|
| Vol 24, No 11 (2024) |
Oncology |
The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
A Number of the N-terminal RASSF Family: RASSF7 |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
Wortmannin Inhibits Cell Growth and Induces Apoptosis in Colorectal Cancer Cells by Suppressing the PI3K/AKT Pathway |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
Ginsenoside Rb1 Inhibits the Proliferation of Lung Cancer Cells by Inducing the Mitochondrial-mediated Apoptosis Pathway |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
The Development of Organotin(IV) N-Ethyl-N-Benzyldithiocarbamate Complexes: A Study on Their Synthesis, Characterization, and Cytocidal Effects on A549 Cell Line |
(Eng)
|
| Vol 24, No 12 (2024) |
Oncology |
Primary Pulmonary Lymphoepithelioma-like Carcinoma: A Case Report Utilizing Camrelizumab and Anlotinib for Prolonged Survival |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
Biosynthesis and Anticancer Activity of Genistein Glycoside Derivatives |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
A Green Synthesis of Au-Ag Alloy Nanoparticles using Polydopamine Chemistry: Evaluation of their Anticancer Potency Towards Both MCF-7 Cells and their Cancer Stem Cells Subgroup |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
Monochasma Savatieri Aqueous Extract inhibits Human Breast Cancer Cell Line Migration and Adhesion Without Generating Toxicity |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
Ionic Liquids Immobilized Synthesis of New Xanthenes Derivatives and their Antiproliferative, Molecular Docking, and Morphological Studies |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
Apoptosis-inducing Metabolite from Marine Mangrove Actinobacteria VITGAP173 |
(Eng)
|
| Vol 24, No 13 (2024) |
Oncology |
Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
A Systematic Review and Meta-analysis of the Relationship between Statin Intake and Esophageal Cancer |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Antidepressant Sertraline Hydrochloride Inhibits the Growth of HER2+ AU565 Breast Cancer Cell Line through Induction of Apoptosis and Cell Cycle Arrest |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Cerium Oxide Nanoparticles Synthesis using Alhagi Maurorum Leaf Extract and Evaluation of Their Cytotoxic Effect on Breast Cancer Cell Lines and Antibacterial Effects |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Novel Piperazine Derivatives as Potent Antihistamine, Anti-Inflammatory, and Anticancer Agents, their Synthesis and Characterization |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer |
(Eng)
|
| Vol 24, No 14 (2024) |
Oncology |
Preparation of a Novel Multifunctional Cationic Liposome Drug-carrying System and its Functional Study on Lung Cancer |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
The Potential Anticancer Potency of Kolaviron on Colorectal Adenocarcinoma (Caco-2) Cells |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
Arsenic Trioxide Suppresses Angiogenesis in Non-small Cell Lung Cancer via the Nrf2-IL-33 Signaling Pathway |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
Optimizing Coreopsis tinctoria Flower Extraction and Inhibiting CML Activity: Box-Behnken Design |
(Eng)
|
| Vol 24, No 15 (2024) |
Oncology |
Synthesis and Biological Evaluation of Thiazole-based Fibroblast Growth Factor Receptor-1 Inhibitors |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
Overexpression of NOP58 Facilitates Proliferation, Migration, Invasion, and Stemness of Non-small Cell Lung Cancer by Stabilizing hsa_circ_0001550 |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes |
(Eng)
|
| Vol 24, No 16 (2024) |
Oncology |
Pistacia vera and its Combination with Cisplatin: A Potential Anticancer Candidate by Modulating Apoptotic Genes |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
Efficacy Analysis of PTCD + TACE vs PTCD + Apatinib in the Treatment of HCC with Obstructive Jaundice: A Retrospective Study |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
Molecular Actions of Enicostemma hyssopifolium Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
PHD-BAH Domain in ASH1L Could Recognize H3K4 Methylation and Regulate the Malignant Behavior of Cholangiocarcinoma |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
A Novel Tryptanthrin Derivative D6 Induces Apoptosis and DNA Damage in Non-small-cell Lung Cancer Cells Through Regulating the EGFR Pathway |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
Arnicolide D Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells through PI3K/Akt/mTOR Pathway |
(Eng)
|
| Vol 24, No 17 (2024) |
Oncology |
Isolation and Characterization of Cytotoxic Compounds from Detarium microcarpum Guill. and Perr. Stem Bark |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
Silibinin Induces Both Apoptosis and Necroptosis with Potential Anti-tumor Efficacy in Lung Cancer |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
The Role of Serine Protease 8 in Mediating Gefitinib Resistance in Non-small Cell Lung Cancer |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab) |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway |
(Eng)
|
| Vol 24, No 18 (2024) |
Oncology |
Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
Relationships of Prodiginins Mechanisms and Molecular Structures to their Antiproliferative Effects |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
Pseudolaric Acid B Inhibits FLT4-induced Proliferation and Migration in Non-small Cell Lung Cancer |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated Orphan Drug, for the Treatment of Hepatocellular Carcinoma |
(Eng)
|
| Vol 24, No 19 (2024) |
Oncology |
Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-bearing Mice: Immunomodulation and Tumor Suppression |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
An Outlook of the Structure Activity Relationship (SAR) of Naphthalimide Derivatives as Anticancer Agents |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
Antitumoral Potential of Artepillin C, a Compound Derived from Brazilian Propolis, against Breast Cancer Cell Lines |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
Osmundacetone Inhibits Angiogenesis of Infantile Hemangiomas through Inducing Caspases and Reducing VEGFR2/MMP9 |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
Preparation of Lycium barbarum Active Glycopeptide and Investigation of Its Apoptotic Effects on Melanoma |
(Eng)
|
| Vol 24, No 2 (2024) |
Oncology |
Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling |
(Eng)
|
| Vol 24, No 20 (2024) |
Oncology |
Immunomodulatory Roles of IL-15 in Immune Cells and its Potential for Cancer Immunotherapy |
(Eng)
|
| Vol 24, No 20 (2024) |
Oncology |
Molecular Activities and Mechanisms of Action of Substances and Molecules from Medicinal Plants from Sub-Saharan Africa on Prostate and Cervical Cancer Cells |
(Eng)
|
| Vol 24, No 20 (2024) |
Oncology |
Effects of Arborvitae (Thuja plicata) Essential Oil on Cervical Cancer Cells: Insights into Molecular Mechanisms |
(Eng)
|
| Vol 24, No 20 (2024) |
Oncology |
FN-1501 Inhibits Diffuse Large B-Cell Lymphoma Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis |
(Eng)
|
| Vol 24, No 20 (2024) |
Oncology |
Lupiwighteone as an Antitumor Agent Reverses Multidrug Resistance in K562/ADR Cells by Regulating Cellular Prion Protein-Oct4 Axis |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
A Comprehensive Review on Nanoparticles as a Targeted Delivery System for the Treatment of Lung Cancer |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
CRD-BP as a Tumor Marker of Colorectal Cancer |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
Research on the Inhibitory Effect of Doxorubicin-loaded Liposomes Targeting GFAP for Glioma Cells |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
Anticancer Potential of a Synthetic Quinoline, 9IV-c, by Inducing Apoptosis in A549 Cell and In vivo BALB/c Mice Models |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
Antitumor Activity of a Lectin Purified from Punica granatum Pulps against Ehrlich Ascites Carcinoma (EAC) Cells |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
An Active Compound from the Pyrazine Family Induces Apoptosis by Targeting the Bax/Bcl2 and Survivin Expression in Chronic Myeloid Leukemia K562 Cells |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
Bunium persicum Seeds Extract in Combination with Vincristine Mediates Apoptosis in MCF-7 Cells through Regulation of Involved Genes and Proteins Expression |
(Eng)
|
| Vol 24, No 3 (2024) |
Oncology |
Novel Anti-tumor Strategy for Breast Cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cells |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Discovery and Development of Promising Anticancer Agents via Computational and Experimental |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunits p50 and p65: A Molecular Docking and Molecular Dynamics Study |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors |
(Eng)
|
| Vol 24, No 4 (2024) |
Oncology |
Exploring the Synergistic Effect of Sildenafil and Green Tea Polyphenols on Breast Cancer Stem Cell-like Cells and their Parental Cells: A Potential Novel Therapeutic Approach |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Karanjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Anti-lung Cancer Activity of Synthesized Substituted 1,4-Benzothiazines: An Insight from Molecular Docking and Experimental Studies |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Synthesis of a Novel Gold(I) Complex and Evaluation of Its Anticancer Properties in Breast Cancer Cells |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MG Glioblastoma Cells via NF-κB and MAPK Signaling Pathways |
(Eng)
|
| Vol 24, No 5 (2024) |
Oncology |
Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Meet the Co-Editor |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
JHD205, A Novel Abemaciclib Derivative, Exerts Antitumor Effects on Breast Cancer by CDK4/6 |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Combination of Ethacrynic Acid and ATRA Triggers Differentiation and/or Apoptosis of Acute Myeloid Leukemia Cells through ROS |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice via Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Turmeric Extract-loaded Selenium Nanoparticles Counter Doxorubicin-induced Hepatotoxicity in Mice via Repressing Oxidative Stress, Inflammatory Cytokines, and Cell Apoptosis |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid |
(Eng)
|
| Vol 24, No 6 (2024) |
Oncology |
Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
Potential of Nanomedicines as an Alternative for the Treatment of Colorectal Cancer - A Review |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents: A Review |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
Design, Synthesis, In vitro and In vivo Evaluation of New Imidazo[1,2-a]pyridine Derivatives as Cyclooxygenase-2 Inhibitors |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with Echis carinatus Venom |
(Eng)
|
| Vol 24, No 7 (2024) |
Oncology |
Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents |
(Eng)
|
| Vol 24, No 8 (2024) |
Oncology |
A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy |
(Eng)
|
| Vol 24, No 8 (2024) |
Oncology |
Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment |
(Eng)
|
| Vol 24, No 8 (2024) |
Oncology |
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021) |
(Eng)
|
| Vol 24, No 8 (2024) |
Oncology |
Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles |
(Eng)
|
| Vol 24, No 8 (2024) |
Oncology |
Drug Repositioning for Ovarian Cancer Treatment: An Update |
(Eng)
|
| Vol 24, No 9 (2024) |
Oncology |
Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and In silico Studies |
(Eng)
|
| Vol 24, No 9 (2024) |
Oncology |
Cordyceps militaris: A Comprehensive Study on Laboratory Cultivation and Anticancer Potential in Dalton's Ascites Lymphoma Tumor Model |
(Eng)
|
| Vol 24, No 9 (2024) |
Oncology |
Anti-proliferative, Morphological and Molecular Docking Studies of New Thiophene Derivatives and their Strategy in Ionic Liquids Immobilized Reactions |
(Eng)
|
| Vol 24, No 9 (2024) |
Oncology |
Antheraea proylei J. Sericin Induces Apoptosis in a Caspase-dependent Manner in A549 and HeLa Cells |
(Eng)
|
| Vol 24, No 9 (2024) |
Oncology |
Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Editorial: (Thematic Issue Cancer Immunotherapy: Does an Increasing Arsenal of Tools Point to More Fruitful Avenues for Research?) |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Editorial (Thematic Issue: Natural Products in Cancer Prevention and Therapy, a selection of topics presented in the 2nd Edition PSE Symposium (Naples, Italy, 25th to 28th of June 2013)) |
(Eng)
|
| Vol 22, No 10 (2022) |
Oncology |
Chemical Constituents and Antitumor Mechanisms of Artemisia |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Focal Adhesion Kinase Regulates Expression of Thioredoxin-interacting Protein (TXNIP) in Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide |
(Eng)
|
| Vol 21, No 2 (2021) |
Oncology |
Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma |
(Eng)
|
| Vol 22, No 11 (2022) |
Oncology |
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma |
(Eng)
|
| Vol 21, No 9 (2021) |
Oncology |
Retracted: The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Antioxidant Activity and Chemical Components as Potential Anticancer Agents in the Olive Leaf (Olea europaea L. cv Leccino.) Decoction |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17 |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
CYP24A1 as a Potential Target for Cancer Therapy |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Implication of CYP24A1 Splicing in Breast Cancer |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Benzothiazoles: How Relevant in Cancer Drug Design Strategy? |
(Eng)
|
| Vol 22, No 6 (2022) |
Oncology |
New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Synthesis and Biological Evaluation of Novel Antifolate Analogs as Potential Anticancer Treatment |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Oxaliplatin-induced Hyperexcitation of Rat Sciatic Nerve Fibers: An Intra-axonal Study |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
New use of Old Drugs: Repurposing of Non-oncology Drugs for Cancer and Oncology Drugs for other Human Diseases |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Repurposing of Various Current Medicines as Radioprotective Agents |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Caracasine, An ent-kaurane Diterpene with Proapoptotic and Pro-differentiator Activity in Human Leukaemia Cell Lines |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Effect of Hybrid Compounds of Stilbene and Pentadienone on Inhibition of Tubulin Polymerization |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Advancements in Small Molecule PROTACs Containing Indole/Spiro-fused Oxindole Scaffolds: An Emerging Degrader Targeting Cancers |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Characterization of Functionalized PLGA Nanoparticles Loaded with Mangiferin and Lupeol, and their Effect on BEAS-2B and HepG2 Cell Lines |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Newly Synthesized Arylazo Derivatives Induce Apoptosis and G2/M Cell Cycle Arrest With Molecular Docking Validation in Human Cancer Cell Lines |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Erianin as a Promising Novel Agent in the Treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Effects of Arctigenin in Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma 5-8F Cells |
(Eng)
|
| Vol 23, No 10 (2023) |
Oncology |
Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and in-vitro Screening |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Research Progress on Gene Synthesis and Anticancer and Lipid-lowering Mechanism of Monacolin K |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Phytochemicals in the Synthetic Era: A Potential Oncosuppressor against Cancer Stem Cells |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Glioblastoma as a Novel Drug Repositioning Target: Updated State |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Application of Polymer Materials in Targeting Glioma |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Chloroform Fraction of Drymaria cordata Linn (CFDC) Suppresses Estradiol Benzoate- Induced Endometrial Hyperplasia |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Gambogic Acid Lysinate-induced Cervical Cancer SiHa Cells Apoptosis in vitro and in vivo |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
JDHY3 Inhibits Hypopharyngeal Carcinoma Cell Proliferation and Promotes Apoptosis by Inhibiting the PI3K/AKT Pathway |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Corrigendum to: Editorial: Anticancer Platinum Complexes - State of the Art and Future Prospects |
(Eng)
|
| Vol 23, No 11 (2023) |
Oncology |
Corrigendum to: Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
NAD+ Consuming Enzymes: Involvement in Therapies and Prevention of Human Diseases |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent Advances |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
LCMS Determination and Cytotoxicity of Abrus precatorius on L6 and SK-N-MC Cell Lines |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
In-silico Evaluation of Novel Honokiol Derivatives against Breast Cancer Target Protein LKB1 |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Anlotinib Inhibits Proliferation and Induces Apoptosis in B-cell Acute Lymphoblastic Leukemia by Targeting the BTK and AKT/mTOR Pathway |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Sauchinone Inhibits the Proliferation and Immune Invasion Capacity of Colorectal Cancer Cells through the Suppression of PD-L1 and MMP2/MM9 |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Isolinderalactone Resistance to the Liver Injury Induced by Oxaliplatin in Rats Through Inhibiting IL-6/STAT3 Signal Pathway |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-Myc |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
New Approaches for the Synthesis N-alkylated Benzo[b]thiophene Derivatives together with their Antiproliferative and Molecular Docking Studies |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Genotoxicity and Anticancer Effects of the Aminothiophene Derivatives SB-44, SB- 83, and SB-200 in Cancer Cells |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Sinularin Exerts Anti-cancer Effects by Inducing Oxidative Stress-mediated Ferroptosis, Apoptosis, and Autophagy in Prostate Cancer Cells |
(Eng)
|
| Vol 23, No 12 (2023) |
Oncology |
Assessment of Cytotoxic/Antitumour Potential and in silico Study of Salazinic Acid Isolated from Parmotrema concurrens |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Meet the Editorial Board Member |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Recent Advancement in the Inhibition of Triple-negative Breast Cancer by N-heterocycles |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Germacrone, A Novel and Safe Anticancer Agent from Genus Curcuma: A Review of its Mechanism |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for the Aspect of Anticancer & Anti-inflammatory Potency |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Natural Products and Gastric Cancer: Cellular Mechanisms and Effects to Change Cancer Progression |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Silybum marianum: An Overview of its Phytochemistry and Pharmacological Activities with Emphasis on Potential Anticancer Properties |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Synthesis, Characteristation and Biological Activity of Silver Nanoparticles Generated Using the Leaf and Stembark Extract of Combretum erythrophyllum |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Some Wild Mushrooms with High Antioxidant Capacity Exhibit Potent Anticancer Activity on Cancer Cells using the Apoptotic and Antimigration Cell Death Mechanisms |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
p-Coumaric Acid Inhibits Osteosarcoma Growth by Inhibiting PI3K/Akt Signaling Pathway |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine |
(Eng)
|
| Vol 23, No 13 (2023) |
Oncology |
Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Akt/mTOR Pathway |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Meet the Editorial Board Member |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Carbon Nanotubes in Breast Cancer Treatment: An Insight into Properties, Functionalization, and Toxicity |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Diterpenoid Tanshinone Attenuates the Metastasis of Non-small-cell Lung Cancer (NSCLC) Cells by Inhibiting the Cavin-1-mediated ERK/Smad2 Signaling Pathway |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Berbamine Inhibits the Biological Activities of Prostate Cancer Cells by Modulating the ROS/NF-κB Axis |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Synthesis and Characterization of Novel 4-aryl-4H-chromene Derivatives using Borax and Evaluation of their Anticancer Effects |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
The Effect of Iron Oxide Nanoparticles of Acalypha wilkesiana Ethyl Acetate Extract on Ehrlich Ascites Carcinoma Cells |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Diosgenin Glucoside Inhibits the Progression of Osteosarcoma MG-63 by Regulating the PI3K/AKT/mTOR Pathway |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Enrichment of Isaria felina Culture with Selenium Enhances its in vivo Antitumor Effects on H22 Hepatoma via Decreasing the Expression of VEGF |
(Eng)
|
| Vol 23, No 14 (2023) |
Oncology |
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Meet the Editorial Board Member |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Cardiotoxicity of Targeted Therapies in Children with Haematological Malignancies and Solid Tumors |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Synthesis and in vitro Anti-proliferative Activities on LNCaP, LS180 and MKN45 of Novel 20(R)-Panaxadiol Derivatives |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
KRAS Mutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Schisandrin B Inhibits Cell Viability and Malignant Progression of Melanoma Cells via Wnt/β-catenin Signaling Pathway |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Surface Modification of Poly(lactide-co-glycolide) Nanoparticles for the Sustained in vitro Release and the Enhanced Cytotoxicity of Chelidonine |
(Eng)
|
| Vol 23, No 15 (2023) |
Oncology |
Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Meet the Editorial Board Member |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Fragment-based Drug Discovery Successful Contributions to Current Pharmacotherapeutic Agents Arsenal against Aggressive Cancers: A Mini-Review |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53 |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Synthesis of S-2-phenylchromane Derivatives and Evaluation of the Antiproliferative Properties as Apoptosis Inducers in Cancer Cell Lines |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Chemical Constituents from the Roots of Jasminum sambac (L.) Ait. and their Cytotoxicity to the Cancer Cell Lines |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Design and Evaluation of SLNs Encapsulated Curcumin-based Topical Formulation for the Management of Cervical Cancer |
(Eng)
|
| Vol 23, No 16 (2023) |
Oncology |
Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Four Decades of the Comet Assay: pH Optimum of Lysis Buffer Still Needs to be Elucidated |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Novel Synthetic Indazoles Abrogate Angiogenesis in Erlich Ascites Tumor Bearing Mice |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
Prebiotics Modulate Gut Microbiota-mediated T-cell Immunity to Enhance the Inhibitory Effect of Sintilimab in Lewis Lung Adenocarcinoma Model Mice |
(Eng)
|
| Vol 23, No 17 (2023) |
Oncology |
The Cytotoxic and Anti-tumor Potential of Methanolic Extracts of Indian Marine Isolates in HCT116 Colorectal Cancer Cells |
(Eng)
|
| Vol 23, No 18 (2023) |
Oncology |
Quercetin-based Nanoformulation: A Potential Approach for Cancer Treatment |
(Eng)
|
| Vol 23, No 18 (2023) |
Oncology |
Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy |
(Eng)
|
| Vol 23, No 18 (2023) |
Oncology |
Venetoclax Synergizes Sunitinib in Renal Cell Carcincoma through Inhibition of Bcl-2 |
(Eng)
|
| Vol 23, No 18 (2023) |
Oncology |
Pulsatilla saponin A Inhibits Proliferation and Induces Apoptosis in Diffuse Large Bcell Lymphoma Cells through the JAK2/STAT3 Signaling Pathway |
(Eng)
|
| Vol 23, No 18 (2023) |
Oncology |
Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells via Abating HIF-1α-Wnt/β-Catenin Signaling Pathway |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
Targeting PPARγ/ NF-κB Signaling Pathway by Britannin, a Sesquiterpene Lactone from Inula aucheriana DC., in Gastric Cancer |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
A Combination of EGFR Inhibitors and AE-PDT Could Synergistically Suppress Breast Cancer Progression |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells |
(Eng)
|
| Vol 23, No 19 (2023) |
Oncology |
Male Breast Cancer: Three Case Reports and a Literature Review |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
A Review on the Use of Gold Nanoparticles in Cancer Treatment |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Cytotoxic and Apoptotic Impacts of Ceranib-2 on RAW 264.7 Macrophage Cells |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Eco-friendly Synthesis and Characterization of Silver Nanoparticles using Juglans regia Extract and their Anti-Trichomonas vaginalis, Anticancer, and Antimicrobial Effects |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
CircFAT1 Promotes the Proliferation and Invasion of Malignant Melanoma through miR375-SLC7A11 Signal Axis |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Arctigenin Suppresses the Proliferation and Metastasis, and Induces Apoptosis and Cycle Arrest of Osteosarcoma Cells by inhibiting HMOX1 Expression |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma Cell Line SK-N-BE(2) Independent of Itraconazole |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
An Antidepressant Drug Increased TRAIL Receptor-2 Expression and Sensitized Lung Cancer Cells to TRAIL-induced Apoptosis |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Multivariate Statistical 2D QSAR Analysis of Indenoisoquinoline-based Topoisomerase- I Inhibitors as Anti-lung Cancer Agents |
(Eng)
|
| Vol 23, No 20 (2023) |
Oncology |
Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
CYP1B1: A Promising Target in Cancer Drug Discovery |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Bakuchiol: A Potential Anticancer Compound from Psoralea corylifolia Linn |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Synthetic Methodologies and SAR of Quinazoline Derivatives as PI3K Inhibitors |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
In silico Study on the Binding Interactions of SSTA and 18F-SSTA Towards Somatostatin Receptor Subtype 2 |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Ginsenoside Rb1 Suppresses AOM/DSS-induced Colon Carcinogenesis |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway |
(Eng)
|
| Vol 23, No 9 (2023) |
Oncology |
Imidazole and Biphenyl Derivatives as Anti-cancer Agents for Glioma Therapeutics: Computational Drug Repurposing Strategy |
(Eng)
|
| Vol 25, No 10 (2025) |
Chemistry |
Advances in VEGFR Inhibitors: A Comprehensive Review of Novel Anticancer Agents |
(Eng)
|
| Vol 25, No 10 (2025) |
Chemistry |
Bioactive Products Targeting C-Met As Potential Antitumour Drugs |
(Eng)
|
| Vol 25, No 10 (2025) |
Chemistry |
Schisanhenol Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Targeting Programmed Cell Death-ligand 1 via the STAT3 Pathways |
(Eng)
|
| Vol 25, No 10 (2025) |
Chemistry |
Rhizopogon luteolus and Ganoderma adspersum Extracts Inhibit Invasion through the Crosstalk between Anti-oxidant Activity and Apoptosis Induced by pAKT/Rb |
(Eng)
|
| Vol 25, No 10 (2025) |
Chemistry |
Investigation of the Anticarcinogenic Effects of Hypericum perforatum Extract on Human Thyroid Cancer |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
Preface |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
An In-depth Review on Argemone mexicana in the Management of Liver Health and Liver Cancer |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
Targeting RSK2 in Cancer Therapy: A Review of Natural Products |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
Clinical Efficacy and Safety of CD7-Targeted CAR T Cell Therapy for T-cell Malignancies: A Systematic Review and Meta-analysis |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent Transcription |
(Eng)
|
| Vol 25, No 1 (2025) |
Oncology |
Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells |
(Eng)
|
| Vol 25, No 11 (2025) |
Chemistry |
Selected Metal (Au, Ag, and Cu) Complexes of N-heterocyclic Ligands as Potential Anticancer Agents: A Review |
(Eng)
|
| Vol 25, No 11 (2025) |
Chemistry |
Origanum syriacum Induces Apoptosis in Lung Cancer Cells by Altering the Ratio of Bax/Bcl2 |
(Eng)
|
| Vol 25, No 11 (2025) |
Chemistry |
Royal Jelly's Strong Selective Cytotoxicity Against Lung Malignant Cells and Macromolecular Alterations in Cells Observed by FTIR Spectroscopy |
(Eng)
|
| Vol 25, No 11 (2025) |
Chemistry |
Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line |
(Eng)
|
| Vol 25, No 11 (2025) |
Chemistry |
Corrigendum to: “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia” |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid Leukemia |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
Cytotoxic Effects of Lecaniodiscus Cupanioides (Planch.) Extract and Triterpenoids-derived Gold Nanoparticles On MCF-7 Breast Cancer Cell Lines |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
Safety and Efficacy of Anlotinib-based Regimen in Patients with Unresectable or Metastatic Bone and Soft-tissue Sarcomas: A Retrospective Institutional Study |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
Optimized Rutin-incorporating PEGylated Nanoliposomes as a Model with Remarkable Selectivity Against PANC1 and MCF7 Cell Lines |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
Cyclic Lipopeptides as Selective Anticancer Agents: In vitro Efficacy on B16F10 Mouse Melanoma Cells |
(Eng)
|
| Vol 25, No 12 (2025) |
Chemistry |
Corrigendum to: Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling |
(Eng)
|
| Vol 25, No 13 (2025) |
Chemistry |
Cucurbitacin E Glucoside as an Apoptosis Inducer in Melanoma Cancer Cells by Modulating AMPK/PGK1/PKM2 Pathway |
(Eng)
|
| Vol 25, No 13 (2025) |
Chemistry |
Anticancer Properties of Phenylboronic Acid in Androgen-Dependent (LNCaP) and Androgen-Independent (PC3) Prostate Cancer Cells via MAP Kinases by 2D and 3D Culture Methods |
(Eng)
|
| Vol 25, No 13 (2025) |
Chemistry |
Effects of Citrus-derived Diosmetin on Melanoma: Induction of Apoptosis and Autophagy Mediated by PI3K/Akt/mTOR Pathway Inhibition |
(Eng)
|
| Vol 25, No 13 (2025) |
Chemistry |
In-silico and In-vitro Molecular Analysis of Oleanolic Acid and Cisplatin on Pancreatic Cancer (Panc-1 Cell Line) |
(Eng)
|
| Vol 25, No 13 (2025) |
Chemistry |
Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents |
(Eng)
|
| Vol 25, No 14 (2025) |
Chemistry |
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems |
(Eng)
|
| Vol 25, No 14 (2025) |
Chemistry |
Design, Synthesis, and Molecular Docking Studies of Indolo[3,2-c]Quinolines as Topoisomerase Inhibitors |
(Eng)
|
| Vol 25, No 14 (2025) |
Chemistry |
Quercetin Suppresses Glioma Stem Cells via Activating p16-INK4 Gene Expression through Epigenetic Regulation |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
Melittin, A Potential Game-changer in the Fight Against Breast Cancer: A Systematic Review |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
HLTF Promotes the Proliferation of Osteosarcoma Cells and Cisplatin Resistance |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
In vitro and In vivo Growth Inhibition and Apoptosis of Cancer Cells by Ethyl 4-[(4-methylbenzyl)oxy] Benzoate Complex |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
Ulvan Microneedles Loaded with Photosensitizer 5-aminolevulinic Acid Inhibits Human Cervical Cancer HeLa Cells In vitro |
(Eng)
|
| Vol 25, No 15 (2025) |
Chemistry |
The Kinesin Eg5 Inhibitor K858 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma and Affects the Expression of Epithelial-mesenchymal Transition Related Markers: In vitro and In vivo Studies |
(Eng)
|
| Vol 25, No 17 (2025) |
Chemistry |
Quercetin’s Potential Therapeutic Role in Human Colorectal Cancer: An Effective Strategy for Prevention and Treatment |
(Eng)
|
| Vol 25, No 17 (2025) |
Chemistry |
Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a Wide Range of Human-derived Cervical Cancer Cell Lines |
(Eng)
|
| Vol 25, No 17 (2025) |
Chemistry |
A Path to the Formation Mechanism of Propolis Nanoparticles, their Cytotoxicity on 3T3 Fibroblasts, Metastatic Murine B16F10 Cells, and their In vivo Irritability in Animals |
(Eng)
|
| Vol 25, No 17 (2025) |
Chemistry |
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment |
(Eng)
|
| Vol 25, No 17 (2025) |
Chemistry |
Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer– In silico and In vitro Evidence |
(Eng)
|
| Vol 25, No 18 (2025) |
Chemistry |
Evaluation of the cagA, dupA, sabA, babA, and iceA1 Gene Expressions in H. pylori Strains Isolated from Patients with Gastric Cancer and Peptic Ulcer Disease |
(Eng)
|
| Vol 25, No 18 (2025) |
Chemistry |
Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
Recent Approaches on Oncolytic Viruses, Aptamers, TTFields and Personalized Treatment used for the Management of Glioblastoma: A Comprehensive Review |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
A Systematic Quantitative Approach to Rational Drug Design and the Discovery of Novel Human Antigen R (HuR) Inhibitors |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
Recurrent Missense Driver STAT5B N642H Mutation in Children Transiting into Adolescence, with Acute Lymphoid Leukemia and its In silico Inhibition |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
Screening of Bioactive Fractions from Balanites aegyptiaca and Pterocarpus marsupium for Anticancer Effects in HepG2 and U87MG Cells |
(Eng)
|
| Vol 25, No 19 (2025) |
Chemistry |
The Role of Cisplatin Prodrugs Bonded to Polymer Carriers for Nanodrug-targeted Treatment of In situ Hepatocellular Carcinoma |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Alterations of Krüppel-like Factor Signaling and Potential Targeted Therapy for Hepatocellular Carcinoma |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Acyl Urea Compounds Therapeutics and its Inhibition for Cancers in Women: A Review |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Utilizing Indigenous Flora in East Africa for Breast Cancer Treatment: An Overview |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Lapatinib: A Potential Therapeutic Agent for Colon Cancer Targeting Ferroptosis |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Exploring Tryptophan-based Short Peptides: Promising Candidate for Anticancer and Antimicrobial Therapies |
(Eng)
|
| Vol 25, No 2 (2025) |
Oncology |
Synthesis of New Chromen-5-one Derivatives from Dimedone and their Antiproliferative Evaluations against Selected Cancer Cell Lines Together with Hepatocellular Carcinoma and Cervical Carcinoma |
(Eng)
|
| Vol 25, No 3 (2025) |
Oncology |
Advancements in Pyrazine Derivatives as Anticancer Agents: A Comprehensive Review (2010-2024) |
(Eng)
|
| Vol 25, No 3 (2025) |
Oncology |
Pioneering the Battle Against Breast Cancer: The Promise of New Bcl-2 Family |
(Eng)
|
| Vol 25, No 3 (2025) |
Oncology |
In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers |
(Eng)
|
| Vol 25, No 3 (2025) |
Oncology |
Anticancer Properties Against Select Cancer Cell Lines and Metabolomics Analysis of Tender Coconut Water |
(Eng)
|
| Vol 25, No 4 (2025) |
Oncology |
Emerging Claudin18.2-targeting Therapy for Systemic Treatment of Gastric Cancer: Seeking Nobility Amidst Danger |
(Eng)
|
| Vol 25, No 4 (2025) |
Oncology |
Doramectin Induces Apoptosis in B16 Melanoma Cells |
(Eng)
|
| Vol 25, No 4 (2025) |
Oncology |
PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes |
(Eng)
|
| Vol 25, No 4 (2025) |
Oncology |
Novel Quinoline Nitrate Derivatives: Synthesis, Characterization, and Evaluation of their Anticancer Activity with a Focus on Molecular Docking and NO Release |
(Eng)
|
| Vol 25, No 4 (2025) |
Oncology |
MG132-mediated Suppression of the Ubiquitin-proteasome Pathway Enhances the Sensitivity of Endometrial Cancer Cells to Cisplatin |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
Role of Natural Compounds as Anti-Cancer Agents |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
Molecular Targets of Plant-based Alkaloids and Polyphenolics in Liver and Breast Cancer- An Insight into Anticancer Drug Development |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
Urea and Thiourea Derivatives of Salinomycin as Agents Targeting Malignant Colon Cancer Cells |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
Current Insights into Therapeutic Potential of Terpenoids as Anticancer Agents |
(Eng)
|
| Vol 25, No 5 (2025) |
Oncology |
A Novel Effective Models for Identifying BRCA Patients and Optimizing Clinical Treatments |
(Eng)
|
| Vol 25, No 6 (2025) |
Oncology |
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer |
(Eng)
|
| Vol 25, No 6 (2025) |
Oncology |
A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy? |
(Eng)
|
| Vol 25, No 6 (2025) |
Oncology |
Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors |
(Eng)
|
| Vol 25, No 6 (2025) |
Oncology |
The Mesoionic 1,3,4-thiadiazolium Derivative, MI-D, is a Potential Drug for Treating Glioblastoma by Impairing Mitochondrial Functions Linked to Energy Provision in Glioma Cells |
(Eng)
|
| Vol 25, No 7 (2025) |
Chemistry |
CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism |
(Eng)
|
| Vol 25, No 7 (2025) |
Chemistry |
Emerging AXL Inhibitors in Oncology: Chemical and Biological Advances in Targeted Cancer Therapy |
(Eng)
|
| Vol 25, No 7 (2025) |
Chemistry |
Pioneering a New Era in Oral Cancer Treatment with Electrospun Nanofibers: A Comprehensive Insight |
(Eng)
|
| Vol 25, No 7 (2025) |
Chemistry |
An Updated Review on Dysregulated lncRNAs and their Contribution to the Various Molecular Types of Lung Carcinoma |
(Eng)
|
| Vol 25, No 7 (2025) |
Chemistry |
In vivo, In vitro, and In silico Studies of Umbelliferone and Irinotecan on MDA-MB-231 Breast Cancer Cell Line and Drosophila melanogaster Larvae |
(Eng)
|
| Vol 25, No 8 (2025) |
Chemistry |
The Dual Role of ADAMTS9-AS1 in Various Human Cancers: Molecular Pathogenesis and Clinical Implications |
(Eng)
|
| Vol 25, No 8 (2025) |
Chemistry |
Screening and in vitro Biological Evaluation of Novel Multiple Tyrosine Kinases Inhibitors as Promising Anticancer Agents |
(Eng)
|
| Vol 25, No 8 (2025) |
Chemistry |
Discovery of a Novel Co-crystal of Chrysin and Oroxylin A with Anticancer Properties from Leaves of Oroxylum indicum |
(Eng)
|
| Vol 25, No 8 (2025) |
Chemistry |
Observation on the Therapeutic Efficacy of Camrelizumab Combined with Chemotherapy in Non-small Cell Lung Cancer and the Cutaneous Immune-related Adverse Events: A Retrospective Study |
(Eng)
|
| Vol 25, No 9 (2025) |
Chemistry |
Quinacrine Inhibits Hepatocellular Carcinoma Growth and Enhances the Anti-HCC Effects of Lenvatinib |
(Eng)
|
| Vol 25, No 9 (2025) |
Chemistry |
Synergistic Anti-tumorigenic Effects of Cabazitaxel and Usnic Acid Combination on Metastatic Castration-Resistant Prostate Cancer Cells |
(Eng)
|
| Vol 25, No 9 (2025) |
Chemistry |
Irisquinone's Anti-cancer Potential: Targeting TrxR to Trigger ROS-mediated Apoptosis and Pyroptosis |
(Eng)
|
| Vol 25, No 9 (2025) |
Chemistry |
Processed Products of Aconitum soongaricum Stapf. Inhibit the Growth of Ovarian Cancer Cells In vivo via Regulating the PI3K/AKT Signal Pathway |
(Eng)
|
| Vol 25, No 9 (2025) |
Chemistry |
Uses of Cyclohexan-1,3-diones to Synthesis Xanthenes Derivatives with Anti-proliferative Activity Against Cancer Cell Lines and their Inhibitions Toward Tyrosine Kinases |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)] |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Hepatocyte Growth Factor and Its Receptor Signalling Complex as Targets in Cancer Therapy |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Anti-Cancer Approach with NK4: Bivalent Action and Mechanisms |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Hepatocyte Growth Factor Activation Inhibitors – Therapeutic Potential in Cancer |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Application of Biological Study for Met Expression to Cancer Therapy |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
The Type II Transmembrane Serine Protease, Matriptase-2: Possible Links to Cancer? |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Barminomycin, a Model for the Development of New Anthracyclines |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Anticancer Activities and Mechanisms of Bisdioxopiperazine Compounds Probimane and MST-16 |
(Eng)
|
| Vol 10, No 1 (2010) |
Oncology |
Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Editorial [Hot Topic : Targeting Focal Ahhesion Kinase in Cancer-Part I (Guest Editor: Vita M. Golubovskaya)] |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Targeting Focal Adhesion Kinase in Neuroblastoma |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Focal Adhesion Kinase as a Cancer Therapy Target |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Focal Adhesion Kinase as a Therapeutic Target of Bortezomib |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Editorial [ Hot Topic:Recent Concepts on Cancer- and Metastasis-Initiating Cells and Their Therapeutic Implications in the Development of Novel Effective Cancer Therapies(Guest Editors: M. Mimeault and S.K. Batra) ] |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Targeting the Acute Myeloid Leukemia Stem Cells |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Multiple Myeloma: A Paradigm for Translation of the Cancer Stem Cell Hypothesis |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Gliomagenesis and the Use of Neural Stem Cells in Brain Tumor Treatment |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Tumor Initiation in Human Malignant Melanoma and Potential Cancer Therapies |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Targeting Ovarian Cancer-Initiating Cells |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Lung Cancer Stem Cells as a Target for Therapy |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Liver Cancer Stem Cells as an Important Target in Liver Cancer Therapies |
(Eng)
|
| Vol 10, No 2 (2010) |
Oncology |
Gestational Trophoblastic Neoplasia, an Ancient Disease: New Light and Potential Therapeutic Targets |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
Silibinin A Promising New Treatment for Cancer |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
Telomere Maintenance as Therapeutic Target in Embryonal Tumours |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
The Vitamin D/CYP24A1 Story in Cancer |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma |
(Eng)
|
| Vol 10, No 3 (2010) |
Oncology |
New Medical Strategies for Midgut Carcinoids |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Editorial [Hot topic:Metal-Containing Drugs and Novel Coordination Complexes in Therapeutic Anticancer Applications Part I (Guest Editor: Irena Kostova)] |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
A Better Platinum-Based Anticancer Drug Yet to Come? |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Mechanisms of Cytotoxicity of Anticancer Titanocenes |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Selenium in the Prevention and Treatment of Hepatocellular Carcinoma |
(Eng)
|
| Vol 10, No 4 (2010) |
Oncology |
Boron-Containing Compounds as Preventive and Chemotherapeutic Agents for Cancer |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Editorial [Hot topic: Metal-Containing Drugs and Novel Coordination Complexes in Therapeutic Anticancer Applications Part II (Guest Editor: Irena Kostova)] |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Recent Researches in Metal Supramolecular Complexes as Anticancer Agents |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Fresh Platinum Complexes with Promising Antitumor Activity |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Progresses in TCM Metal-Based Antitumour Agents |
(Eng)
|
| Vol 10, No 5 (2010) |
Oncology |
Compounds from Wild Mushrooms with Antitumor Potential |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy Part I (Guest Editor: Hui-Wen Lo)] |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Obesity Modulation - The Role in Carcinogenesis |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design |
(Eng)
|
| Vol 10, No 6 (2010) |
Oncology |
Combination Therapy with Arsenic Trioxide for Hematological Malignancies |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Editorial [Hot topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy Part II (Guest Editor: Hui-Wen Lo)] |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
STAT3 as a Therapeutic Target for Glioblastoma |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
The Potential of Tetrandrine Against Gliomas |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Emerging Therapeutic Targets and Agents for Glioblastoma Migrating Cells |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Doxycycline in Mitochondrial Mediated Pathway of Apoptosis: A Systematic Review |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Antimetastatic Activities and Mechanisms of Bisdioxopiperazine Compounds |
(Eng)
|
| Vol 10, No 7 (2010) |
Oncology |
Updates of mTOR Inhibitors |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Editorial [Hot Topic: Multidrug Resistance: Genes, Polymorphisms, Biologic Effects, Reversal and Treatment in Cancer Chemotherapy (Guest Editor: Jeanny B. Aragon-Ching)] |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Pomegranate Extract, A Prooxidant with Antiproliferative and Proapoptotic Activities Preferentially Towards Carcinoma Cells |
(Eng)
|
| Vol 10, No 8 (2010) |
Oncology |
Blockade of MUC1 Expression by Glycerol Guaiacolate Inhibits Proliferation of Human Breast Cancer Cells |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
FK506 Binding Proteins as Targets in Anticancer Therapy |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough? |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
Potential New Agents for Chronic Lymphocytic Leukemia Treatment |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends |
(Eng)
|
| Vol 10, No 9 (2010) |
Oncology |
Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Editorial [Hot Topic: Rising of Phosphatases as Targets of Cancer Treatment (Guest Editor: Petr Heneberg)] |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Can We Effectively Degrade Microcystins? - Implications on Human Health |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Recent Advances in Protein Tyrosine Phosphatase Detection Using Chemical Probes |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Regulatory Cascades of Protein Phosphatases: Implications for Cancer Treatment |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
SHP-1 in Cell-Cycle Regulation |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
High-Throughput Methods in Identification of Protein Tyrosine Phosphatase Inhibitors and Activators |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors |
(Eng)
|
| Vol 11, No 1 (2011) |
Oncology |
Metal-Based Inhibitors of Protein Tyrosine Phosphatases |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Editorial [Hot Topic: Gold Derivatives as Anti-Cancer Agents (Guest Editor: Laura Rodriguez Raurell)] |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Protein Targets for Anticancer Gold Compounds: Mechanistic Inferences |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Strategies for the Biological Evaluation of Gold Anticancer Agents |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Gold Nanostructures as Photothermal Therapy Agent for Cancer |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
SMILES-based QSAR Approaches for Carcinogenicity and Anticancer Activity: Comparison of Correlation Weights for Identical SMILES Attributes |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
TEM8 Targeted Cancer Therapy |
(Eng)
|
| Vol 11, No 10 (2011) |
Oncology |
Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer: Pro- vs Anti-Oxidative Mode of Action-Part I (Guest Editor: Ines Batinic-Haberle)] |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Superoxide Dismutases: Anti- Versus Pro- Oxidants? |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Does More MnSOD Mean More Hydrogen Peroxide? |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Mitochondrial Superoxide Dismutase - Signals of Distinction |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
The Potential of Zn(II) N-Alkylpyridylporphyrins for Anticancer Therapy |
(Eng)
|
| Vol 11, No 2 (2011) |
Oncology |
The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)] |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Anticancer Effects of Garlic and Garlic-derived Compounds for Breast Cancer Control |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Modulation of Histone Acetylation by Garlic Sulfur Compounds |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Anti-Proliferative Activity of Synthetic Ajoene Analogues on Cancer Cell-Lines |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
BRAF as a Target for Cancer Therapy |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug |
(Eng)
|
| Vol 11, No 3 (2011) |
Oncology |
Lenalidomide Current Understanding of Mechanistic Properties |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)] |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Superoxide Dismutase in Redox Biology: The Roles of Superoxide and Hydrogen Peroxide |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Nitroxides as Cancer Imaging Agents |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Cellular Uptake and Organ Accumulation of Amphipolar Metallocorroles with Cytoprotective and Cytotoxic Properties |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias |
(Eng)
|
| Vol 11, No 4 (2011) |
Oncology |
Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)] |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
An Update on Molecular Research of Pancreatic Adenocarcinoma |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Combination Therapy for the Treatment of Pancreatic Cancer |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Aptamers: Potential Applications to Pancreatic Cancer Therapy |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma? |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer from Molecular Signalling to Clinical Trials |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Anti-Angiogenic Agents in Pancreatic Cancer: A Review |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms |
(Eng)
|
| Vol 11, No 5 (2011) |
Oncology |
Resveratrol and Its Analogues: Promising Antitumor Agents |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Editorial [Hot Topic: Recent Advances Into the Molecular Mechanisms and Therapeutic Targeting of Hepatocellular Carcinoma (Guest Editors: Dr. Mei-Sze Chua and Li Wang)] |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Molecular Mechanisms of Liver Cancer |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
microRNA Involvement in Hepatocellular Carcinoma |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Role of Stem Cells in Normal Liver and Cancer |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Role of Class II Nuclear Receptors in Liver Carcinogenesis |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma |
(Eng)
|
| Vol 11, No 6 (2011) |
Oncology |
Hepatocellular Carcinoma Detection by Gallium Scan and Subsequent Treatment by Gallium Maltolate: Rationale and Case Study |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Editorial [Hot topic: Focal Adhesion Kinase Signaling in Cancer- Part II (Guest Editor: Vita M. Golubovskaya)] |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
FAK and WNT Signaling: The Meeting of Two Pathways in Cancer and Development |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
FAK and p53 Protein Interactions |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Coordinated Expression of Pax-5 and FAK1 in Metastasis |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Nanoparticles in Oncology: The New Theragnostic Molecules |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Nitroimidazoles as Anti-Tumor Agents |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Editorial [Hot Topic: Targeted Therapy for Glioblastoma Multiforme (Guest Editor: Marc-Eric Halatsch)] |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Nucleic Acid-Based Therapeutics for Glioblastoma |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Therapeutic Strategies to Target Multiple Kinases in Glioblastoma |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Angiogenesis in Glioblastoma Multiforme: Navigating the Maze |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Erlotinib in Glioblastoma - Lost in Translation? |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Effect of Selenium-Saturated Bovine Lactoferrin (Se-bLF) on Antioxidant Enzyme Activities in Human Gut Epithelial Cells Under Oxidative Stress |
(Eng)
|
| Vol 11, No 8 (2011) |
Oncology |
Update on Laser Photochemotherapy: An Alternative for Cancer Treatment |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)] |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Targeting Sphingosine-1-Phosphate in Hematologic Malignancies |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Regulation of Sphingosine Kinase in Hematological Malignancies and Other Cancers |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Targeting Sphingosine-1-Phosphate Receptors in Cancer |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
S1P Regulation of Macrophage Functions in the Context of Cancer |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Ceramidases in Hematological Malignancies: Senseless or Neglected Target? |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Regulation of Autophagy by Sphingolipids |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
The Gut-To-Breast Connection - Interdependence of Sterols and Sphingolipids in Multidrug Resistance and Breast Cancer Therapy |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Ceramide Transfer Protein and Cancer |
(Eng)
|
| Vol 11, No 9 (2011) |
Oncology |
Ceramide-Based Therapeutics for the Treatment of Cancer |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Preface |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Editorial [Hot Topic: Targeting G Protein and Phosphorylation Dependent Signalling Molecules for Anticancer Therapy (Guest Editor: Jeyanthy Eswaran)] |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Atypical GTPases as Drug Targets |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Targeting Cancer Using Fragment Based Drug Discovery |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Natural Products: Promising Resources for Cancer Drug Discovery |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging |
(Eng)
|
| Vol 12, No 1 (2012) |
Oncology |
New Targeted Therapies for Anaplastic Thyroid Cancer |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Editorial [Hot Topic: Natural Compounds as Cancer Chemopreventive and Chemotherapeutic Agents: Insights Gained from Mechanistic and Pharmacologic Studies] |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Chemoprevention of Breast Cancer by Dietary Compounds |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Epigenetic Mechanisms Underlying Diet-Sourced Compounds in the Prevention and Treatment of Gastrointestinal Cancer |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
The Cancer Preventive Effects of Edible Mushrooms |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability |
(Eng)
|
| Vol 12, No 10 (2012) |
Oncology |
Developing Phytoestrogens for Breast Cancer Prevention |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)] |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Anticancer Activity of Bisphosphonates in Breast Cancer |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Bisphosphonate Anticancer Activity in Multiple Myeloma |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Bisphosphonates in Lung Cancer: Can They Provide Benefits Beyond Prevention of Skeletal Morbidity? |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Bisphosphonates and Breast Cancer Prevention |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers? |
(Eng)
|
| Vol 12, No 2 (2012) |
Oncology |
Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Editorial [ Special Board Members Issue (Edior-in-Chief: Michelle Prudhomme)] |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
The Stem Cell Niche as a Pharmaceutical Target for Prevention of Skeletal Metastases |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1 |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Melanoma and Epigenetic Treatment: Past and Future |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Curcumin and its Formulations: Potential Anti-Cancer Agents |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Chemotherapeutic Targeting of Cell Death Pathways |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Selective Histone Deacetylase Inhibitors |
(Eng)
|
| Vol 12, No 3 (2012) |
Oncology |
Genistein and its Synthetic Analogs as Anticancer Agents |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Editorial [Hot Topic: Lipids in Cancer Cell Biology and Therapy Guest Editor: Jose C. Fernandez-Checa)] |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Sphingolipid Modulation: A Strategy for Cancer Therapy |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Statins and Protein Prenylation in Cancer Cell Biology and Therapy |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Cholesterol, Cardiolipin, and Mitochondria Permeabilisation |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Ganglioside GD3 as a Raft Component in Cell Death Regulation |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds |
(Eng)
|
| Vol 12, No 4 (2012) |
Oncology |
Downregulation of Hypoxia-related Responses by Novel Antitumor Histone Deacetylase Inhibitors in MDAMB231 Breast Cancer Cells |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
EDITORIAL [Hot Topic: Peptide-Receptor Ligands in Imaging and Therapy of Cancer (Guest Editor: Dr. Paolo Ruzza)] |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Peptide-Receptor Ligands and Multivalent Approach |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Molecular Imaging of Cancer with Radiolabeled Peptides and PET |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Drug Targeting Strategies for Photodynamic Therapy |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Boronated Compounds for Imaging Guided BNCT Applications |
(Eng)
|
| Vol 12, No 5 (2012) |
Oncology |
Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Neutrophil Elastase as a Target in Lung Cancer |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Anticoagulant and Fibrinolytic Drugs Possible Agents in Treatment of Lung Cancer? |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Current and Emerging Strategies in Bladder Cancer |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Gallium Phthalocyanine Photosensitizers: Carboxylation Enhances the Cellular Uptake and Improves the Photodynamic Therapy of Cancers |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Anticancer Activity and Anti-inflammatory Studies of 5-Aryl-1,4-benzodiazepine Derivatives |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Cranberry as Promising Natural Source of Potential Anticancer Agents: Current Evidence and Future Perspectives |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Effects of Bioactive Compounds from Carrots (Daucus carota L.), Polyacetylenes, Beta-Carotene and Lutein on Human Lymphoid Leukaemia Cells |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421 |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors |
(Eng)
|
| Vol 12, No 6 (2012) |
Oncology |
Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
PREFACE [Hot Topic: Novel Cancer-Targeting Agents/Application Strategies Developed from MMP Science] |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review) |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Modulation of MMPs by Cell Surface Integrin Receptor α5β1 |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
MicroRNAs in Cancer: Small Molecules, Big Chances |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
MMPs in Ovarian Cancer as Therapeutic Targets |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice |
(Eng)
|
| Vol 12, No 7 (2012) |
Oncology |
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
EDITORIAL (Hot Topic: Natural Polyphenols Properties: Chemopreventive and Chemosensitizing Activities) |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Flavonoids in Cancer Prevention |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Regulation of Cell Death and Survival by Resveratrol: Implications for Cancer Therapy |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Natural-derived Polyphenols as Potential Anticancer Agents |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Probing the Interaction of Anti-Cancer Agent Dihydromyricetin with Human Serum Albumin: A typical Method Study |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Structures Required of Flavonoids for Inhibiting Digestive Enzymes |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Bovine Serum Albumin Significantly Improves the DPPH Free Radical Scavenging Potential of Dietary Polyphenols and Gallic Acids |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Fig Latex (Ficus carica L. cultivar Dottato) in Combination with UV Irradiation Decreases the Viability of A375 Melanoma Cells In Vitro |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines |
(Eng)
|
| Vol 12, No 8 (2012) |
Oncology |
Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation? |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand? |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation? |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Anti-cancer Effects of Curcumin on Head and Neck Cancers |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Dual Roles of Sulforaphane in Cancer Treatment |
(Eng)
|
| Vol 12, No 9 (2012) |
Oncology |
Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Preface |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Editorial (Hot Topic: Vitamin D and Cancer: Current Evidence and Future Perspective) |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Safety Issues of Vitamin D Supplementation |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Epidemiology of Vitamin D and Colorectal Cancer |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012? |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Relevance of Vitamin D in Bone and Muscle Health of Cancer Patients |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Vitamin D, Sunlight and Cancer Connection |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Sunlight Vitamin D and Skin Cancer |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Vitamin D and Breast Cancer Incidence and Outcome |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Vitamin D Supplementation and Cancer: Review of Randomized Controlled Trials |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
The Anti-cancer Actions of Vitamin D |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics |
(Eng)
|
| Vol 13, No 1 (2013) |
Oncology |
New Insight into P-Glycoprotein as a Drug Target |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Editorial (Thematic Issue: Green Anti-Cancer Agents and Ayur-Biotechnology: A smart approach towards improving R&D productivity.) |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
First Ayurvedic Approach Towards Green Drugs: Anti Cervical Cancer-Cell Properties of Clerodendrum viscosum Root Extract |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Betulin-Betulinic Acid Natural Product Based Analogs as Anti-Cancer Agents |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Chemoprevention of Skin Cancer: Effect of Lawsonia inermis L. (Henna) Leaf Powder and its Pigment Artifact, Lawsone in the Epstein- Barr Virus Early Antigen Activation Assay and in Two-Stage Mouse Skin Carcinogenesis Models |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Curcumin Potentiates The Ability of Sunitinib to Eliminate the VHL-lacking Renal Cancer Cells 786-O: Rapid Inhibition of Rb Phosphorylation as a Preamble to Cyclin D1 Inhibition |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Stereoselective Synthesis of Pyroglutamate Natural Product Analogs from α- Aminoacids and their Anti-Cancer Evaluation |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Dendrimer-Curcumin Conjugate: A Water Soluble and Effective Cytotoxic Agent Against Breast Cancer Cell Lines |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Garcinia Benzophenones Inhibit the Growth of Human Colon Cancer Cells and Synergize with Sulindac Sulfide and Turmeric |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Editorial: Plant Derived Secondary Metabolites as Anti-Cancer Agents |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Cinnamaldehyde-Induced Apoptosis in Human Hepatoma PLC/PRF/5 Cells Involves the Mitochondrial Death Pathway and is Sensitive to Inhibition by Cyclosporin A and z-VAD-fmk |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Myricetin Induces Apoptosis in HepG2 Cells Through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Synthesis and Biological Evaluation of Diaryl Ether Linked DC-81 Conjugates as Potential Antitumor Agents |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
Effects of Limonoid Cedrelone on MDA-MB-231 Breast Tumor Cells in vitro |
(Eng)
|
| Vol 13, No 10 (2013) |
Oncology |
ACKNOWLEDGEMENTS TO THE REVIEWERS |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Editorial (Hot Topic: Translational Medicine is Promoting Cross-talk of Interdiscipline) |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Antiangiogenic Triterpenes Isolated from Chinese Herbal Medicine Actinidia chinensis Planch |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Cell Dormancy and Tumor Refractory |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Functional Nanoplatforms for Enhancement of Chemotherapeutic Index |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
A Cohort Study and Meta-Analysis between Histopathological Classification and Prognosis of Gastric Carcinoma |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
UGT1A1 Gene Polymorphisms and the Toxicities of FOLFIRI in Chinese Han Patients with Gastrointestinal Cancer |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
DNA Methylation as a Target of Epigenetic Therapeutics in Cancer |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Conventional Chemotherapy and Emerging Targeted Therapy for Advanced Adrenocortical Carcinoma |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Antidepressant Desipramine Leads to C6 Glioma Cell Autophagy: Implication for the Adjuvant Therapy of Cancer |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
BRCA2 Dysfunction Promotes Malignant Transformation of Pancreatic Intraepithelial Neoplasia |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
The Role of Mesothelin in Tumor Progression and Targeted Therapy |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Platinum Compounds: A Hope for Future Cancer Chemotherapy |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Experimental and Theoretical Advances in Functional Understanding of Flavonoids as Anti-Tumor Agents |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells |
(Eng)
|
| Vol 13, No 2 (2013) |
Oncology |
The Effect of Quercetin on Doxorubicin Cytotoxicity in Human Breast Cancer Cells |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents) |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Heterocyclic Chalcone Analogues as Potential Anticancer Agents |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Biology and Medicinal Chemistry Approaches Towards Various Apoptosis Inducers |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Targeting Heme for the Identification of Cytotoxic Agents |
(Eng)
|
| Vol 13, No 3 (2013) |
Oncology |
Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential after Priming with Paclitaxel |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors) |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Cell Survival Signaling in Neuroblastoma |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
The Role of Focal Adhesion Kinase in Lung Cancer |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
FAK and HAS Inhibition Synergistically Decrease Colon Cancer Cell Viability and Affect Expression of Critical Genes |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Synthesis and Anticancer Properties of a Novel Bis-intercalator |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
SJSZ Glycoprotein (38 kDa) Inhibits Cell Cycle and Oxidative Stress in N-Methyl-N`- nitro-N-nitrosoguanidine-induced ICR Mice |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Editorial (Hot Topic:Recent Advance in the Studies of Beta-glucans for Cancer Therapy) |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
The Use of Lentinan for Treating Gastric Cancer |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
The Effects of β -Glucans on Dendritic Cells and Implications for Cancer Therapy |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
The Effects of β-glucans on Cancer Metastasis |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
β -Glucans and their Applications in Cancer Therapy: Focus on human studies |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Syntetic Oligosacharides Clinical Application in Cancer Therapy |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
The Application of Fungal Beta-glucans for the Treatment of Colon Cancer |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Antiproliferative Activities on Renal, Prostate and Melanoma Cancer Cell Lines of Sarcopoterium spinosum Aerial Parts and its Major Constituent Tormentic Acid |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
NF-κB Downregulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
The Role of Autophagic Cell Death and Apoptosis in Irinotecan-treated p53 Null Colon Cancer Cells |
(Eng)
|
| Vol 13, No 5 (2013) |
Oncology |
Cancer Antibody Enhanced Real Time Imaging Cell Probes a Novel Theranostic Tool using Polymer Linked Carbon Nanotubes and Quantum Dots |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
EDITORIAL(Hot Topic Integrated Therapeutic Approaches in the Treatment of Human Cancer) |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Integrated Therapeutic Approaches in Head and Neck Cancer: The Importance of Multidisciplinary Team Management |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Integrated Therapeutic Approaches in the Treatment of Locally Advanced Non-small Cell Lung Cancer |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Multidisciplinary Approach to Rectal Cancer: Are we Ready for Selective Treatment Strategies? |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Multidisciplinary Treatment of Early Stage Endometrial Cancer |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Multidisciplinary Approach to Patient with Malignant Melanoma |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Sugar-Borate Esters Potential Chemical Agents in Prostate Cancer Chemoprevention |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Natural Flora and Anticancer Regime: Milestones and Roadmap |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Baicalin Suppresses Migration, Invasion and Metastasis of Breast Cancer via p38MAPK Signaling Pathway |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Structural Effects of TiO2 Nanoparticles and Doxorubicin on DNA and their Antiproliferative Roles in T47D and MCF7 Cells |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Cucurmosin Kills Human Pancreatic Cancer SW-1990 Cells in vitro and in vivo |
(Eng)
|
| Vol 13, No 6 (2013) |
Oncology |
Synthesis, Selective Cancer Cytotoxicity and Mechanistic Studies of Novel Analogs of Lantadenes |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products) |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Hitting the Golden TORget: Curcumin's Effects on mTOR Signaling |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Tocotrienols Target PI3K/Akt Signaling in Anti-Breast Cancer Therapy |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
From Bacteria to Antineoplastic: Epothilones A Successful History |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Suppression of Oncoprotein Her-2 and DNA Damage after Treatment with Flavan-3- ol Vitis labrusca Extract |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
BIBR 1532 Increases Arsenic Trioxide-mediated Apoptosis in Acute Promyelocytic Leukemia Cells: Therapeutic Potential for APL |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells |
(Eng)
|
| Vol 13, No 7 (2013) |
Oncology |
Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
EDITORIAL (Thematic Issue: Nutrition Plays a Profound Role in Cancer Prevention and Survivorship) |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Evidence for Anti-Cancer Properties of Blueberries: A Mini-Review |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Pomegranate Extracts and Cancer Prevention: Molecular and Cellular Activities |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Omega-3 Polyunsaturated Fatty Acids and Cancer |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Soy and Its Isoflavones: The Truth Behind the Science in Breast Cancer |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
β-Hydroxy-β-Methylbutyrate as a Countermeasure for Cancer Cachexia: A Cellular and Molecular Rationale |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Assessment of Nutritional Status in Cancer The Relationship Between Body Composition and Pharmacokinetics |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Naturally-occurring Dimers of Flavonoids as Anticarcinogens |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
The Role of Phenolic Compounds in the Fight against Cancer A Review |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Selection and Characterization of Human Anti-MAGE-A1 scFv and Immunotoxin |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Celecoxib Inhibits Helicobacter pylori-induced Invasion of Gastric Cancer Cells Through an Adenine Nucleotide Translocator-Dependent Mechanism |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Muscarinic Activation Enhances the Anti-proliferative Effect of Paclitaxel in Murine Breast Tumor Cells |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Glaucocalyxin A and B-induced Cell Death is Related to GSH Perturbation in Human Leukemia HL-60 Cells |
(Eng)
|
| Vol 13, No 8 (2013) |
Oncology |
Synthesis of Novel Steroid Derivatives Derived from Dehydroepiandrosterone as Potential Anticancer Agents |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Editorial (Thematic Issue: Elderly Cancer Patients in the 3rd Millenium: Between Hope and Reality. Introduction) |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Geriatric Evaluation of Oncological Elderly Patients |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Cancer, Aging and Immune Reconstitution |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Medical Treatment Of Elderly Patients With Breast Cancer |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Colorectal Cancer in Elderly Patients: From Best Supportive Care to Cure |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Onco-Surgical Management of Colo-Rectal Liver Metastases in Older Patients: A New Frontier in the 3rd Millennium |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Gastrointestinal Non Colorectal Cancer. Do Elderly Patients Need a Specific Management? |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Hepatocellular Carcinoma: Beyond the Boundaries of Age |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Treatment of Elderly Patients Affected by Lung Cancer: Why to Treat, when to Treat and what we Know |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Treatment Approaches in Elderly Patients with Head and Neck Cancer |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Genito-Urological Cancers in Elderly Patients |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Skin Cancers in Elderly Patients |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Management Of Elderly Patients With Diffuse Large B-Cell Lymphomas |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Autologus Stem Cell Transplatation as a Care Option in Elderly Patients. A Review |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Is Effective and Safe a Radiochemotherapy Approach in Elderly Cancer Patients? A Review |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Hematopoietic Growth Factors Support in the Elderly Cancer Patients Treated with Antiblastic Chemotherapy |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Novel Molecular Anti- Colorectalcancer Conjugate:Chlorambucil-Adipic Acid Dihydrizide-Glutamine |
(Eng)
|
| Vol 13, No 9 (2013) |
Oncology |
Discovery of P3971 an Orally Efficacious Novel Anticancer Agent Targeting HIF-1α and STAT3 Pathways |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Preface |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Editorial (Thematic Issue: Focal Adhesion Kinase and Cross-Linked Signaling In Cancer) |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Focal Adhesion Kinase Regulates Expression of Thioredoxin-interacting Protein (TXNIP) in Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Editorial (Thematic Issue: Cytochrome P450 for Cancer Prevention and Therapy) |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17 |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
CYP24A1 as a Potential Target for Cancer Therapy |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Implication of CYP24A1 Splicing in Breast Cancer |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Adenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Benzothiazoles: How Relevant in Cancer Drug Design Strategy? |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
White Poplar (Populus alba L.) Suspension Cultures as a Model System to Study Apoptosis Induced by Alfalfa Saponins |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Improving the Efficacy of Plant Polyphenols |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Pro-Oxidative Action of Polyphenols as Action Mechanism for their Pro-Apoptotic Activity |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Intracellular Distribution and Biological Effects of Phytochemicals in a Sex Steroid- Sensitive Model of Human Prostate Adenocarcinoma |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Drug Target Strategies in Breast Cancer Treatment: Recent Developments |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Synthesis, Preferentially Hypoxic Apoptosis and Anti-Angiogenic Activity of 3- Amino-1,2,4-Benzotriazine-1,4-Dioxide Bearing Alkyl Linkers with a 3-Amino-1,2,4- Benzotriazine-1-Oxide Moiety |
(Eng)
|
| Vol 14, No 10 (2014) |
Oncology |
Acknowledgements to the Reviewers |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Poxvirus-Based Vaccines for Cancer Immunotherapy: New Insights from Combined Cytokines/Co-Stimulatory Molecules Delivery and "Uncommon" Strains |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
HPV-Specific Immunotherapy: Key Role for Immunomodulators |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Green Tea Catechins: Proposed Mechanisms of Action in Breast Cancer Focusing on the Interplay Between Survival and Apoptosis |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Synthesis and Structure Activity Relationship Study of N-substituted 3,5-diarylidenepiperidin- 4-ones as Potential Antitumor Agents |
(Eng)
|
| Vol 14, No 2 (2014) |
Oncology |
Electrochemical Study of Ellipticine Interaction with Single and Double Stranded Oligonucleotides |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Preface |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Editorial (Thematic Issue: Focal Adhesion Kinase and Cross-Linked Signaling In Cancer) |
(Eng)
|
| Vol 14, No 1 (2014) |
Oncology |
Editorial (Thematic Issue: Cytochrome P450 for Cancer Prevention and Therapy) |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Editorial (Thematic Issue: The Effects of Anticancer Agents on Cell Apoptosis and on the Expression of Cancer - Related Genes) |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Apoptosis-related BCL2-family Members: Key Players in Chemotherapy |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Effect of Cytostatic Drugs on the mRNA Expression Levels of Ribonuclease κ in Breast and Ovarian Cancer Cells |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Microtubule-targeting Anticancer Agents from Marine Natural Substance |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Recent Advances in Small Molecule Prodrugs for Cancer Therapy |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Phytochemical and Biological Activities of an Anticancer Plant Medicine: Brucea javanica |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Anticancer Activity of Ferrocenylthiosemicarbazones |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents |
(Eng)
|
| Vol 14, No 3 (2014) |
Oncology |
Chemically Synthesized Matrix Metalloproteinase and Angiogenesis-inhibiting Peptides as Anticancer Agents |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Editorial (Thematic Issue: Antitumor Alkylphospholipid Analogs: A Promising and Growing Family of Synthetic Cell Membrane-Targeting Molecules for Cancer Treatment) |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Edelfosine in Membrane Environment - the Langmuir Monolayer Studies |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Lipid Rafts, Endoplasmic Reticulum and Mitochondria in the Antitumor Action of the Alkylphospholipid Analog Edelfosine |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3 |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
1-O-Octadecyl-2-O-Methylglycero-3-phosphocholine (Edelfosine) and Cancer Cell Invasion: A Short Review |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Antitumoral Alkylphospholipids Alter Cell Lipid Metabolism |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Glycosylated Antitumor Ether Lipids: Activity and Mechanism of Action |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Glycosidated Phospholipids a Promising Group of Anti-Tumour Lipids |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Combining Anti-tumor Alkyl-Phospholipid Analogs and Radiotherapy: Rationale and Clinical Outlook |
(Eng)
|
| Vol 14, No 4 (2014) |
Oncology |
Current View on the Mechanism of Action of Perifosine in Cancer |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Editorial (Thematic Issue: Treatment of Cancer in the Elderly) |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Tools For Decision-Making In Older Cancer Patients. Role Of The Comprehensive Geriatric Assessment |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
New Drugs for Follicular Lymphoma in Older Adults |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
The Potential of Acridine Carboxamide Pt Complexes as Anti-Cancer Agents : A Review |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Statins and Cancer |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Damnacanthal: A Promising Compound as a Medicinal Anthraquinone |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
East-West FusionNecrosis and Apoptosis Acting in Concert by Demethylcantharidin-Integrated Platinum Complexes |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
Steroidal Cardiac Na+/K+ ATPase Inhibitors Exhibit Strong Anti-Cancer Potential in vitro and in Prostate and Lung Cancer Xenografts in vivo |
(Eng)
|
| Vol 14, No 5 (2014) |
Oncology |
3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Editorial (Thematic Issue: Phytochemicals, Intracellular Signalling Pathways and Anti-Cancer Effects) |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin- 3-Gallate |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Curcumin: A Promising Agent Targeting Cancer Stem Cells |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Garlic-Derived Allyl Sulfides in Cancer Therapy |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Nanoparticle-Delivered Quercetin for Cancer Therapy |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Paris polyphylla: Chemical and Biological Prospectives |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Targetability and Biodistribution of Radioiodinated Hypericin: Comparison between Microdosing and Carrier-Added Preparations |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2 |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells |
(Eng)
|
| Vol 14, No 6 (2014) |
Oncology |
Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Anti-Cancer Agent-Induced Nephrotoxicity |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
EGFRIndb: Epidermal Growth Factor Receptor Inhibitor Database |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Betulinic Acid as a Potent and Complex Antitumor Phytochemical: A Minireview |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Chalcone-Coumarin Derivatives as Potential Anti-Cancer Drugs: An in vitro and in vivo Investigation |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Sesamol Ameliorates Cyclophosphamide-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammatory Mediators |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Synthesis and Biological Evaluation of 3-Substituted-4-(4-methylthio phenyl)-1HPyrrole Derivatives as Potential Anticancer Agents |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Modeling Study of Phenylsulfonylfuroxan Derivatives as P-gp Inhibitors: A Combined Approach of CoMFA, CoMSIA and HQSAR |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents |
(Eng)
|
| Vol 14, No 7 (2014) |
Oncology |
ent-Kaurane Diterpenoids from Croton tonkinensis Induce Apoptosis in Colorectal Cancer Cells through the Phosphorylation of JNK Mediated by Reactive Oxygen Species and Dual-Specificity JNK Kinase MKK4 |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Editorial (Thematic Issue: Emerging Concepts and Therapeutics Strategies for the Treatment of Brain Tumors) |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Therapeutic Targeting of Malignant Glioma |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Translational Gap in Glioma Research |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Hecogenin Acetate Inhibits Reactive Oxygen Species Production and Induces Cell Cycle Arrest and Senescence in the A549 Human Lung Cancer Cell Line |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Baicalin Induces Apoptosis of Gallbladder Carcinoma Cells in vitro via a Mitochondrial-Mediated Pathway and Suppresses Tumor Growth in vivo |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Cucurbitacin B Induces DNA Damage, G2/M Phase Arrest, and Apoptosis Mediated by Reactive Oxygen Species (ROS) in Leukemia K562 Cells |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
A Steroidal Na+/K+ ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells |
(Eng)
|
| Vol 14, No 8 (2014) |
Oncology |
Dinuclear Berenil-Platinum (II) Complexes as Modulators of Apoptosis in Human MCF-7 and MDA-MB231 Breast Cancer Cells |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Follow the ATP: Tumor Energy Production: A Perspective |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Histone Deacetylase Inhibitors and Colorectal Cancer: what is new? |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Ellagic Acid Inhibits VEGF/VEGFR2, PI3K/Akt and MAPK Signaling Cascades in the Hamster Cheek Pouch Carcinogenesis Model |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Synthesis and In Vitro Antiproliferative Activity of Thiazole-Based Nitrogen Mustards: The Hydrogen Bonding Interaction between Model Systems and Nucleobases |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Chalcones Incorporated Pyrazole Ring Inhibit Proliferation, Cell Cycle Progression, Angiogenesis and Induce Apoptosis of MCF7 Cell Line |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Effect of two Antiandrogens as Protectors of Prostate and Brain in a Huntington`s Animal Model |
(Eng)
|
| Vol 14, No 9 (2014) |
Oncology |
Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Overview |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Preface |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
BRCA1 as Target for Breast Cancer Prevention and Therapy |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Neoadjuvant Strategies for Triple Negative Breast Cancer: 'State-of-the-art' and Future Perspectives |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma? |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
A Review on Antiproliferative and Apoptotic Activities of Natural Honey |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
In Search of Natural Remediation for Cervical Cancer |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Novel Triazolyl Berberine Derivatives Prepared via CuAAC Click Chemistry: Synthesis, Anticancer Activity and Structure-Activity Relationships |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Bleomycin Induced Sensitivity to TRAIL/Apo-2L-Mediated Apoptosis in Human Seminomatous Testicular Cancer Cells is Correlated with Upregulation of Death Receptors |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
DNA Binding and Anticancer Activity of Novel Cyclometalated Platinum (II) Complexes |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Synthesis and Cytotoxic Properties of Halogen and Aryl-/Heteroarylpiperazinyl Derivatives of Benzofurans |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Evaluation of Tricine and EDDA as Co-ligands for 99mTc-Labeled HYNIC-MSH Analogs for Melanoma Imaging |
(Eng)
|
| Vol 15, No 1 (2015) |
Oncology |
Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Editorial (Thematic Issue: Special Thematic Issue: Crossreactivity in Cancer and Autoimmunity) |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Viruses and Oral Cancer: Crossreactivity as a Potential Link |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Natural and Induced Antibody Polyreactivity |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Immunogenicity, Immunopathogenicity, and Immunotolerance in One Graph |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Role of Rap2 and its Downstream Effectors in Tumorigenesis |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Screening Novel SAHA Derivatives as Anti-lung Carcinoma Agents: Synthesis, Biological Evaluation, Docking Studies and Further Mechanism Research between Apoptosis and Autophagyetween Apoptosis and Autophagy |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Revision of the Synthesis and Pharmacological Activity of a Reported Translation Inhibitor |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
Synthesis and Biological Evaluation of Quinazoline Derivatives as Potential Anticancer Agents (II) |
(Eng)
|
| Vol 15, No 10 (2015) |
Oncology |
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Curcumin-Based Anti-Prostate Cancer Agents |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
p42.3: An Abductor of Cell Cycle |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Recent Developments on Thiourea Based Anticancer Chemotherapeutics |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Poly(Ethylene Glycol) Amphiphilic Copolymer for Anticancer Drugs Delivery |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Liposome Encapsulated All Trans Retinoic Acid (ATRA) has Enhanced Immunomodulatory and Inflammation Reducing Activities in Mice Model |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Synthesis of Nitroaromatic Compounds as Potential Anticancer Agents |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Cystine Dimethyl Ester Induces Apoptosis Through Regulation of PKC-δ and PKC-ε in Prostate Cancer Cells |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Anti-Proliferative Activities of Terpenoids Isolated from Alisma orientalis and their Structure-Activity Relationships |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Growth Inhibition of Various Human Cancer Cell Lines by Imperatorin and Limonin from Poncirus Trifoliata Rafin. Seeds |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
HUHS1015 Induces Necroptosis and Caspase-Independent Apoptosis of MKN28 Human Gastric Cancer Cells in Association with AMID Accumulation in the Nucleus |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Toxic Effects of Aflatoxin B1 on Embryonic Development of Zebrafish (Danio rerio): Potential Activity of Piceatannol Encapsulated Chitosan/poly (Lactic Acid) Nanoparticles |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Anticancer Activity and Mechanism Investigation of Beauvericin Isolated from Secondary Metabolites of the Mangrove Endophytic Fungi |
(Eng)
|
| Vol 15, No 2 (2015) |
Oncology |
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Editorial (Thematic Issue: Discovery and Biosynthesis of Natural Products with Anti-Cancer Activities) |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Identification and Characterization of the Biosynthetic Gene Cluster of Thiolutin, a Tumor Angiogenesis Inhibitor, in Saccharothrix algeriensis NRRL B-24137 |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
PreQ0 Base, an Unusual Metabolite with Anti-cancer Activity from Streptomyces qinglanensis 172205 |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
The Cytotoxic and Mechanistic Effects of Aaptamine on Hepatocellular Carcinoma |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Marizomib, A Potent Second Generation Proteasome Inhibitor from Natural Origin |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’? |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Using Cytochalasins to Improve Current Chemotherapeutic Approaches |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Gold Nanoparticle-Lignan Complexes Inhibited MCF-7 Cell Proliferation in vitro: A Novel Conjugation for Cancer Therapy |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Isothiouronium Salts Reduce NRAS Expression, Induce Apoptosis and Decrease Invasion of Melanoma Cells |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Targeting Mitochondrial Citrate Transport in Breast Cancer Cell Lines |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Synthesis and Anticancer Activity Evaluation of Some Benzothiazole-Piperazine Derivatives |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma |
(Eng)
|
| Vol 15, No 3 (2015) |
Oncology |
Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Combined Anticancer Therapies: An Overview of the Latest Applications |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Small Molecules for Immunomodulation in Cancer: A Review |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Differential Interactions of Cytochrome P450 3A5 and 3A4 with Chemotherapeutic Agent-Vincristine: A Comparative Molecular Dynamics Study |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma via Akt Signaling Pathway |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation |
(Eng)
|
| Vol 15, No 4 (2015) |
Oncology |
Epoxomicin Sensitizes Resistant Osteosarcoma Cells to TRAIL Induced Apoptosis |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Meet Our Editor |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Editorial (Thematic Issue: "Discovery and Development of New Anticancer Drugs Inspired from Natural Product Leads" Part 1) |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Design and Synthesis of Novel Antineoplastic Agents Inspired from Marine Bromopyrrole Alkaloids |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Synthesis of Novel Amides Based on Acridone Scaffold with Interesting Antineoplastic Activity |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Recent Developments Towards Podophyllotoxin Congeners as Potential Apoptosis Inducers |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Anticancer Activity of Polyether Ionophore-Salinomycin |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Curcumin as an Adjuvant to Breast Cancer Treatment |
(Eng)
|
| Vol 15, No 5 (2015) |
Oncology |
Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Molecular Treatment of Different Breast Cancers |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
The Use of Anthracyclines for Therapy of CNS Tumors |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Apigenin and Breast Cancers: From Chemistry to Medicine |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH2Ph)]Br |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
A Novel Cobalt(II) Coordination Complex Constructed from H2Pyri and 4,4′-Bipy: Synthesis, Characterization and Bioactivity |
(Eng)
|
| Vol 15, No 6 (2015) |
Oncology |
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Meet Our Editorial Board Member: |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments) |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Is Notch Signaling a Specific Target in Hepatocellular Carcinoma? |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Recent Advance in Drug Development of Squamous Cell Carcinoma |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Advances in the Development of Site-Specific Antibody-Drug Conjugation |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Current Molecularly Targeting Therapies in NSCLC and Melanoma |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
RUNX2 and Osteosarcoma |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice |
(Eng)
|
| Vol 15, No 7 (2015) |
Oncology |
A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Meet Our Editorial Board Member: |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Editorial (Thematic Issue: "Discovery and Development of New Anticancer Drugs Inspired from Natural Product Leads" Part 2) |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Anti-cancer Glycosidase Inhibitors from Natural Products: A Computational and Molecular Modelling Perspective |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
An Insight into Purine, Tyrosine and Tryptophan Derived Marine Antineoplastic Alkaloids |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Novel Series of Coumarinyl Substituted-thiazolidin-2,4-dione Analogs as Anticancer Agents: Design, Synthesis, Spectral Studies and Cytotoxicity Evaluation |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Anticancer Agents Derived from Natural Cinnamic Acids |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Acridone-based Antitumor Agents: A Mini-review |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Cancer Chemoprevention by Natural Carotenoids as an Efficient Strategy |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Coumarin: A Promising Scaffold for Anticancer Agents |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
Current Perspective of Natural Alkaloid Carbazole and its Derivatives as Antitumor Agents |
(Eng)
|
| Vol 15, No 8 (2015) |
Oncology |
5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Meet Our Editorial: |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Chemomodulating Effects of Flavonoids in Human Leukemia Cells |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Synthesis of Isoxazole Moiety Containing Thieno[2,3-d]pyrimidine Derivatives and Preliminarily in vitro Anticancer Activity (Part II) |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Intracellular ROS Generation Mediates Maleimide-induced Cytotoxicity in Leukemia Cells |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Cytotoxic, Antiproliferative and Apoptotic Effects of New Benzimidazole Derivatives on A549 Lung Carcinoma and C6 Glioma Cell Lines |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents |
(Eng)
|
| Vol 15, No 9 (2015) |
Oncology |
Synthesis and characterization of a new retinoic acid ECPIRM as potential chemotherapeutic agent for human cutaneous squamous carcinoma |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Meet Our Editorial Board Member: |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Overview |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Editorial (Thematic Issue: Antitarget Therapies: New Frontiers in the Treatment of Cancer) |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Therapeutic Use of MicroRNAs in Cancer |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101 |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Targeting Cancer Stem Cells: Promises and Challenges |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
CXCR4 and Glioblastoma |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Therapeutic Potential of Targeting PAK Signaling |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths? |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
The Immune System in Cancer Prevention, Development and Therapy |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia |
(Eng)
|
| Vol 16, No 1 (2016) |
Oncology |
Preface |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents) |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Flavonoids with Therapeutic Potential in Prostate Cancer |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Inhibitors of Cancer Stem Cells |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Diazenyl Derivatives and their Complexes as Anticancer Agents |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Synthesis of Diflunisal Thiazolidinones as Anticancer Agents |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Investigation of Fucoidan-Oleic Acid Conjugate for Delivery of Curcumin and Paclitaxel |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
1,3,4-Thiadiazole Based Anticancer Agents |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site |
(Eng)
|
| Vol 16, No 10 (2016) |
Oncology |
Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Disulfiram's Anticancer Activity: Evidence and Mechanisms |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Synthesis of Arylamino-1,3,5-triazines Functionalized with Alkylatin 2-chloroethylamine Fragments and Studies of their Cytotoxicity on the Breast Cancer MCF-7 Cell Line |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro & In Vivo Screening, Docking Analysis |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain |
(Eng)
|
| Vol 16, No 11 (2016) |
Oncology |
Exploring the Binding Affinity of Novel Syringic Acid Analogues and Critical Determinants of Selectivity as Potent Proteasome Inhibitors |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Meet Our Editorial Board Member |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer? |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Mutant B-Raf Kinase Inhibitors as Anticancer Agents |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Aryl Maleimides as Apoptosis Inducers on L5178-Y Murine Leukemia Cells (in silico, in vitro and ex vivo Study) |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
The cytotoxic effect of GW843682X on nasopharyngeal carcinoma |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity |
(Eng)
|
| Vol 16, No 12 (2016) |
Oncology |
Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties |
(Eng)
|
| Vol 16, No 2 (2016) |
Oncology |
Meet Our Editorial Board Member: |
(Eng)
|
| Vol 16, No 2 (2016) |
Oncology |
Acetogenins as Potential Anticancer Agents |
(Eng)
|
| Vol 16, No 2 (2016) |
Oncology |
Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review |
(Eng)
|
| Vol 16, No 2 (2016) |
Oncology |
Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination |
(Eng)
|
